SEB Asset Management AB purchased a new stake in shares of Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report) in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 98,762 shares of the financial services provider’s stock, valued at approximately $17,130,000.
Other institutional investors have also recently bought and sold shares of the company. Swiss National Bank raised its stake in shares of Marsh & McLennan Companies by 6.6% during the 1st quarter. Swiss National Bank now owns 1,437,800 shares of the financial services provider’s stock worth $249,386,000 after purchasing an additional 89,500 shares during the period. Mediolanum International Funds Ltd grew its position in Marsh & McLennan Companies by 143.7% during the first quarter. Mediolanum International Funds Ltd now owns 46,622 shares of the financial services provider’s stock valued at $8,146,000 after buying an additional 27,492 shares during the period. Spartan Wealth Advisory Services LLC purchased a new stake in Marsh & McLennan Companies during the first quarter worth about $212,000. Kinsale Capital Group Inc. bought a new stake in Marsh & McLennan Companies in the first quarter worth about $8,584,000. Finally, Jennison Associates LLC purchased a new position in Marsh & McLennan Companies in the first quarter valued at about $38,609,000. Institutional investors own 87.99% of the company’s stock.
Marsh & McLennan Companies Stock Performance
Shares of MRSH stock opened at $181.82 on Tuesday. The company has a market cap of $87.84 billion, a P/E ratio of 22.73, a price-to-earnings-growth ratio of 2.74 and a beta of 0.61. Marsh & McLennan Companies, Inc. has a 12 month low of $156.60 and a 12 month high of $213.80. The company has a debt-to-equity ratio of 1.28, a quick ratio of 1.11 and a current ratio of 1.11.
Marsh & McLennan Companies Increases Dividend
Wall Street Analysts Forecast Growth
Several equities research analysts have recently issued reports on the stock. Keefe, Bruyette & Woods raised their price target on shares of Marsh & McLennan Companies from $200.00 to $203.00 and gave the stock a “market perform” rating in a research note on Friday, April 17th. Citigroup raised Marsh & McLennan Companies from a “neutral” rating to a “buy” rating and set a $200.00 price objective for the company in a report on Wednesday, May 6th. UBS Group raised their target price on Marsh & McLennan Companies from $203.00 to $212.00 and gave the stock a “buy” rating in a research report on Wednesday, July 8th. Barclays dropped their price target on Marsh & McLennan Companies from $209.00 to $206.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 8th. Finally, Wells Fargo & Company cut their price target on Marsh & McLennan Companies from $203.00 to $178.00 and set an “equal weight” rating for the company in a research note on Thursday, April 9th. One research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, ten have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $200.81.
Read Our Latest Stock Report on MRSH
Insider Buying and Selling at Marsh & McLennan Companies
In other news, CEO John Q. Doyle sold 16,656 shares of Marsh & McLennan Companies stock in a transaction on Tuesday, June 2nd. The stock was sold at an average price of $161.71, for a total value of $2,693,441.76. Following the completion of the transaction, the chief executive officer directly owned 116,811 shares in the company, valued at approximately $18,889,506.81. The trade was a 12.48% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 0.38% of the company’s stock.
Marsh & McLennan Companies Profile
Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.
The firm operates through several well-known subsidiaries and business units that specialize in distinct services.
Further Reading
- Five stocks we like better than Marsh & McLennan Companies
- The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence
- Is Domino’s Stock Serving Up a Buying Opportunity?
- A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free
- Why Gold Miners Could Be the Market’s Biggest Comeback Story
Want to see what other hedge funds are holding MRSH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report).
Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.
